Final results of a phase II Danish trial testing low dose total body irradiation (LTBI) following Six bi-weekly RCHOP-14 plus 2 extra Rituximab (R) in elderly high risk patients with aggressive CD20+ diffuse large B-cell lymphoma (DLBCL)

Authors :: Safwat, Akmal
Specht, L
Hansen, F
Hansen, M
Jurlander, J
d'Amore, Francesco Annibale
Source :: Safwat, A, Specht, L, Hansen, F, Hansen, M, Jurlander, J & d'Amore, F A 2008, ' Final results of a phase II Danish trial testing low dose total body irradiation (LTBI) following Six bi-weekly RCHOP-14 plus 2 extra Rituximab (R) in elderly high risk patients with aggressive CD20+ diffuse large B-cell lymphoma (DLBCL) ', Blood, no. (Suppl. ASH, dec. 2008) .
Publication Year :: 2008

Language :: English
Database :: OpenAIRE
Journal :: Safwat, A, Specht, L, Hansen, F, Hansen, M, Jurlander, J & d'Amore, F A 2008, ' Final results of a phase II Danish trial testing low dose total body irradiation (LTBI) following Six bi-weekly RCHOP-14 plus 2 extra Rituximab (R) in elderly high risk patients with aggressive CD20+ diffuse large B-cell lymphoma (DLBCL) ', Blood, no. (Suppl. ASH, dec. 2008) .
Accession number :: edsair.pure.au.......571a7cceaebda1e4a986e3cc2286f5ed

Tools